Sterilization Monitoring Market Impact of Rising Healthcare-Associated Infections

The global sterilization monitoring market was valued at USD 962.8 million in 2024 and is projected to reach USD 1,843.2 million by 2033, with a compound annual growth rate (CAGR) of 7.57% from 2025 to 2033. This market is experiencing substantial growth due to several key factors. A notable increase in Healthcare-Associated Infections (HAIs) globally and a rising number of inpatient surgeries are significant drivers.

The increasing prevalence of HAIs is expected to play a crucial role in the growth of the sterilization monitoring market. Hospitals and clinics face ongoing pressure to enhance sterilization standards to mitigate risks associated with inadequately sterilized equipment. For example, data released by the European Centre for Disease Prevention and Control in May 2024 indicates that around 4.3 million hospitalized patients in the EU and European Economic Area (EEA) are impacted by HAIs each year. These infections pose serious health risks and impose substantial burdens on healthcare systems.

Another critical factor is the stringent regulatory environment. Global governments and health authorities enforce rigorous sterilization standards, prompting healthcare organizations to implement effective monitoring systems. In November 2024, the FDA issued guidance titled "Transitional Enforcement Policy for Ethylene Oxide Sterilization Facility Changes for Class III Devices." This policy provides transitional enforcement discretion for manufacturers of specific Class III devices, addressing expected changes in ethylene oxide (EtO) sterilization processes and helping to minimize potential disruptions or shortages in the medical device supply chain as facilities adapt to new Environmental Protection Agency (EPA) regulations.

**** 

Key Market Trends & Insights

• North America held the largest share of the sterilization monitoring market, accounting for 35.49% of revenue in 2024.
• The U.S. represented the largest share within North America, contributing 67.84% of regional revenue in 2024.
• In terms of technology, the biological indicators segment dominated the market with a revenue share of 58.12% in 2024.
• By product, the strips segment is anticipated to grow at the fastest CAGR of 8.08% during the forecast period.
• Regarding method, the steam sterilization segment led the market with the highest revenue share in 2024.

Order a free sample PDF of the Sterilization Monitoring Market Intelligence Study, published by Grand View Research.

**** 

Market Size & Forecast

• 2024 Market Size: USD 962.8 Million
• 2033 Projected Market Size: USD 1,843.2 Million
• CAGR (2025-2033): 7.57%
• North America: Largest market in 2024

**** 

Key Companies & Market Share Insights

The sterilization monitoring market is moderately fragmented, featuring both major and local competitors. Given the efforts of existing players to capture larger market shares, intense competition is anticipated, which could increase further. Many market participants are undertaking various strategic initiatives, including product launches, mergers and acquisitions, and geographic expansions, to secure a competitive advantage. As a result, the market is expected to experience growth during the forecast period.

**** 

Key Players

• 3M
• ASP
• STERIS
• Solventum
• Getinge
• Propper Manufacturing Co., Inc.
• LISTER BioMedical
• GKE (Mesa Labs, Inc.)
• Hu-Friedy
• Zhejiang Tailin Bioengineering Co., Ltd.
• Miracle Industries
• STERIVIC Medical Co., Ltd
• Cole-Parmer Instrument Company, LLC.
• Terragene
• Anhui Tianrun Medical Packaging Materials Co., Ltd.
• Tuttnauer
• Andersen Sterilizers
• MMM Group
• MATACHANA
• HiMedia Laboratories
• Steelco S.p.A

**** 

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

**** 

Conclusion

The sterilization monitoring market is on a growth trajectory driven by rising cases of healthcare-associated infections, regulatory pressures, and an increasing number of inpatient procedures. Continued advancements in sterilization technology and strategic initiatives by market players are likely to foster an environment of innovation and competition, ultimately enhancing the market landscape over the forecast period.